These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 36014850)

  • 1. Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
    Zhu H; Bai M; Xie X; Wang J; Weng C; Dai H; Chen J; Han F; Lin W
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease.
    Wang J; Zhou C; Zhang Q; Liu Z
    Amino Acids; 2023 Nov; 55(11):1563-1572. PubMed ID: 37736814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between bone turnover markers and renal disease in elderly patients with type 2 diabetes: a cross-sectional study.
    Wei S; Pan X; Wei J
    BMC Endocr Disord; 2024 Sep; 24(1):179. PubMed ID: 39237970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum metabolomics detected by LDI-TOF-MS can be used to distinguish between diabetic patients with and without diabetic kidney disease.
    Qian F; Zhao L; Zhang D; Yu M; Zhou W; Jin J
    FEBS Open Bio; 2023 Oct; 13(10):1844-1858. PubMed ID: 37525631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic Profiling of Amino Acids in Human Plasma Distinguishes Diabetic Kidney Disease From Type 2 Diabetes Mellitus.
    Zhou C; Zhang Q; Lu L; Wang J; Liu D; Liu Z
    Front Med (Lausanne); 2021; 8():765873. PubMed ID: 34912824
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes.
    Liu T; Zhao H; Wang Y; Qu P; Wang Y; Wu X; Zhao T; Yang L; Mao H; Peng L; Zhan Y; Li P
    Front Immunol; 2024; 15():1334109. PubMed ID: 38481996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.
    Luo M; Zhang Z; Lu Y; Feng W; Wu H; Fan L; Guan B; Dai Y; Tang D; Dong X; Yun C; Hocher B; Liu H; Li Q; Yin L
    Int Urol Nephrol; 2023 Apr; 55(4):1001-1013. PubMed ID: 36255506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients.
    Li L; Wang C; Yang H; Liu S; Lu Y; Fu P; Liu J
    Mol Biosyst; 2017 Oct; 13(11):2392-2400. PubMed ID: 28956034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between gain in adiposity and diabetic kidney disease worsening in type 2 diabetes is mediated by deteriorating glycaemic control: A 3-year follow-up analysis.
    Moh AMC; Wang J; Tan C; Ang SF; Ang K; Subramaniam T; Sum CF; Kwan PY; Lee SBM; Tang WE; Lim SC
    Diabetes Res Clin Pract; 2019 Nov; 157():107812. PubMed ID: 31401149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus.
    Zhang X; Xiao J; Li X; Cui J; Wang K; He Q; Liu M
    Front Endocrinol (Lausanne); 2022; 13():915494. PubMed ID: 35784547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic profiling reveals the step-wise alteration of bile acid metabolism in patients with diabetic kidney disease.
    Zhang Q; Lu L; Wang J; Lu M; Liu D; Zhou C; Liu Z
    Nutr Diabetes; 2024 Oct; 14(1):85. PubMed ID: 39384774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles metabolic changes reveals plasma signature in stage-dependent diabetic kidney disease.
    Pan Y; Yang H; Chen T; Jin J; Ruan L; Hu L; Chen L
    Ren Fail; 2022 Dec; 44(1):1840-1849. PubMed ID: 36368309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into serum metabolic biomarkers for early detection of incident diabetic kidney disease in Chinese patients with type 2 diabetes by random forest.
    Jiang JJ; Sham TT; Gu XF; Chan CO; Dong NP; Lim WH; Song GF; Li SM; Mok DK; Ge N
    Aging (Albany NY); 2024 Feb; 16(4):3420-3530. PubMed ID: 38349886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease.
    Liu JJ; Ghosh S; Kovalik JP; Ching J; Choi HW; Tavintharan S; Ong CN; Sum CF; Summers SA; Tai ES; Lim SC
    Kidney Int Rep; 2017 May; 2(3):470-480. PubMed ID: 29142974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry.
    Lin HT; Cheng ML; Lo CJ; Lin G; Liu FC
    Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
    Zhang J; Fuhrer T; Ye H; Kwan B; Montemayor D; Tumova J; Darshi M; Afshinnia F; Scialla JJ; Anderson A; Porter AC; Taliercio JJ; Rincon-Choles H; Rao P; Xie D; Feldman H; Sauer U; Sharma K; Natarajan L
    Am J Nephrol; 2022; 53(2-3):215-225. PubMed ID: 35196658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.